Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience.
Not available.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ferrata Storti Foundation
2024-10-01
|
| Collection: | Haematologica |
| Accès en ligne: | https://haematologica.org/article/view/11808 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|